33 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
the Chairman can focus on leading the Board in its fundamental role of providing advice to and independent oversight of management. Specifically, the Chair … director due to her employment as Chief Executive Officer of the Company.
Board Oversight of Risk Management
Our management is primarily responsible
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
and manufacturers of medicinal products are subject to comprehensive regulatory oversight by the EMA, the European Commission and/or the competent … applicable regulatory authorities’ legal requirements, regulations and guidelines, and remain subject to oversight by these governmental agencies and ethics
F-3/A
x5b6btbhlgdccoqtd
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm
F-3/A
7dp2fu85hj1vmnc9626
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
F-3
evil1g iiopk
5 Aug 21
Shelf registration (foreign)
4:33pm
F-3
EX-1.2
xs0mey
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
EX-1.1
qb8v2p76vpnfj
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
424B5
gr60pfa 2z
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
fv6ec 99kfvs7
9 Feb 21
Prospectus supplement for primary offering
5:24pm
424B5
ee9n5m vte8u26b0n7
23 Oct 20
Prospectus supplement for primary offering
4:40pm
F-3
wkm4 facdqhn
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
EX-1.2
ry2l78
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
pmlgc mu1
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
i66selj zdtn8
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm